Results 11 to 20 of about 188,223,062 (256)

Recognition of maturity‐onset diabetes of the young in China

Journal of Diabetes Investigation, 2021
Aims/Introduction Given that mutations related to maturity‐onset diabetes of the young (MODY) are rarely found in Chinese populations, we aim to characterize the mutation spectrum of MODY pedigrees.
Hua Liang, Yanan Zhang, Maixinyue Li, Jinhua Yan, Daizhi Yang, Sihui Luo, Xueying Zheng, Guoqing Yang, Zhuo Li, Wen Xu, Leif Groop, Jianping Weng   +11 more
doaj   +2 more sources

Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know? [PDF]

Diabetes & Metabolism Journal, 2015
Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes that is characterized by an early onset, autosomal dominant mode of inheritance and a primary defect in pancreatic β-cell function.
Sung-Hoon Kim
doaj   +2 more sources

Maturity-Onset Diabetes of Young Type 5: Diabetes with Extrapancreatic Features

Case Reports in Endocrinology, 2021
Objective. This case involves a new-onset diabetes patient diagnosed during pregnancy with the congenital dysplastic right kidney. Case Report. Clinical presentation, biochemical features, imaging in a patient with diabetes diagnosed during pregnancy ...
Adnan Haider, Oksana Symczyk, Ayesha Hassan, Muhammad Atif Khan, Inderpreet Madahar, Dylan Holland   +5 more
doaj   +2 more sources

Maturity onset diabetes of the young: Diagnosis and treatment options

Russian Open Medical Journal, 2016
Diabetes is a complicated disease, so multiple factors are involved in its development. Nevertheless some of the patients with type 1 and 2 diabetes mellitus have a monogenic form of this disease which has different treatment options and usually fewer ...
Serghei Covanțev, Andrian Chiriac, Ludmila Perciuleac, Vladlena Zozina   +3 more
doaj   +2 more sources

Homozygous hypomorphic HNF1A alleles are a novel cause of young-onset diabetes and result in sulphonylurea sensitive diabetes [PDF]

, 2020
OBJECTIVE Heterozygous loss-of-function mutations in HNF1A cause maturity-onset diabetes of the young (MODY). Affected individuals can be treated with low-dose sulphonylureas.
Colclough, Kevin, hassanali, neelam, Misra, Shivani, Valabhji, Jonathan, Bennet, Amanda, Gloyn, Anna, Oliver, Nick, Juszczak, Agata, Ellard, Sian, Caswell, Richard   +9 more
core   +1 more source

Maturity-onset diabetes of the young: A proposal for updated nomenclature. [PDF]

J Diabetes Investig
Given the contemporary understanding of diabetes genetics, the term maturity-onset diabetes of the young (MODY) warrants renaming.
Tosur M.
europepmc   +2 more sources

Objective and Subjective Sleep Patterns in Adults with Maturity-Onset Diabetes of the Young (MODY)

, 2023
   Article highlights: a) To examine sleep patterns in patients with Maturity-Onset Diabetes of the Young. b) Are sleep disturbances common in Maturity-Onset Diabetes of the Young?
Louis H. Philipson (8561265), Maria V. Salguero (14280215), Kristen Wroblewski (614763), Esra Tasali (14280220), Rochelle N. Naylor (9140375), Marilyn Arosemena (14280206)   +5 more
core   +1 more source

Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families [PDF]

, 2009
OBJECTIVE - To investigate the prevalence of maturity-onset diabetes of the young (MODY) in Italian children With incidental hyperglycemia. RESEARCH DESIGN AND METHODS - Among 748 subjects age 1-18 years with incidental hyperglycemia, minimal diagnostic ...
ITALIAN SOCIETY OF PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY ISPED STUDY GROUP, Minuto, N, N. Minuto, C. Klersy, Lorini, R, O. Massa, Klersy, C, O. F. Pediatric Endocrinology Italian Society, d'Annunzio G, F. Cerutti, Manca Bitti, ML, S. Toni, FRANZESE, ADRIANA, Klersy C, G. D'Annunzio, Massa, O, Meschi, F, F. Barbetti, VANELLI, Maurizio, Meschi F, F. Meschi, Barbetti F, Italian Society of Pediatric Endocrinology, Italian Society of Pediatric Endocrinology and Diabetology (ISPED) Study Group, Iafusco D, Diabetology Study G.r.o.u.p., Minuto N, Bellannè Chantelot C, Iafusco, D, Frongia, A, Massa O, Cerutti F, Barbetti, F, Frongia AP, Toni S, Cerutti, F, Frongia, Ap, R. Lorini, C. Bellanne Chantelot, D. Iafusco, SULLI, Nicoletta, Lorini R, Toni, S, IAFUSCO, Dario, A. P. Frongia, Diabetology Study Group, Pinelli L., D'Amato E., Bellannè-Chantelot, C, Sulli N., Cotellessa M., Franzese A., Guazzarotti L., Lorini R., Pocecco M., Meschi F., Cadario F., Crino A., Toni S., Mancabitti M. L., Meossi C., Visentin A., Cappa M., Cherubini V., Vanelli M., Massa O., Frongia A. P., Bellanne-Chantelot C., Scaramuzza A., Banin P., Minuto N., Chiari G., Iafusco D., Klersy C., Barbetti F., d'Annunzio, G, Cerutti, Franco, Calisti L., Iughetti L., D'Annunzio G., Cerutti F., Cauvin V.   +81 more
core   +1 more source

Association of GCK Gene Promoter Polymorphism and their Role in its mRNA Expression among Type 2 Diabetes Mellitus Patients [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Glucokinase (GCK) gene alteration or inactivation leads to Maturity-Onset Diabetes of the Young (MODY) and Neonatal Diabetes. Alterations in GCK gene has been shown to be associated with increased risk of type 2 diabetes, hyperglycaemia
WASEEM FATIMA, Farah Khan, Ashraf Ali, Amit Kumar Verma   +3 more
doaj   +1 more source

Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment [PDF]

Yeungnam University Journal of Medicine, 2020
Maturity-onset diabetes of the young (MODY) is a clinically heterogeneous group of monogenic disorders characterized by ß-cell dysfunction. MODY accounts for between 2% and 5% of all diabetes cases, and distinguishing it from type 1 or type 2 diabetes is
Kyung Mi Jang
doaj   +1 more source